SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001016169-22-000022
Filing Date
2022-03-03
Accepted
2022-03-03 08:10:03
Documents
15
Period of Report
2022-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-20220303.htm   iXBRL 8-K 38169
2 EX-99.1 atrs-20220303x8kexx991.htm EX-99.1 280583
6 GRAPHIC atrs-20220303_g1.jpg GRAPHIC 48666
7 GRAPHIC gbzjl4uq45ct000001.jpg GRAPHIC 44018
  Complete submission text file 0001016169-22-000022.txt   674762

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrs-20220303.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrs-20220303_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrs-20220303_pre.xml EX-101.PRE 13068
9 EXTRACTED XBRL INSTANCE DOCUMENT atrs-20220303_htm.xml XML 11821
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 22706793
SIC: 3841 Surgical & Medical Instruments & Apparatus